Platelet biomarkers for the detection of disease
A biomarker, platelet technology, applied to these same tumours, could solve the problem of not providing a reliable indication of angiogenic activity.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0209]Circulating platelets contain a variety of regulators capable of modifying the angiogenic process. The ability of platelets to attach to abnormal surfaces and release their contents in the local environment makes them a highly desirable form of local angiogenic factor delivery. In physiological conditions of angiogenesis, this strictly local release of growth factors represents a highly flexible, safe and efficient system for wound healing or regeneration; but in pathological conditions, such as in cancer, chronic inflammatory disorders or vascular abnormalities , which represents a critical paracrine amplification loop for growth.
[0210] Platelets have a number of mechanisms for this controlled, highly ordered and locally reactive activity:
i) Platelet microparticles (PMPs) are shed during tumor progression: tumor vasculature is known to activate platelets, mainly because of its open and highly irregular endothelial cell surface; PMPs containing VEGF, bFGF and other...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 